Inhibrx Biosciences (INBX) Leases (2023 - 2025)
Historic Leases for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $6.0 million.
- Inhibrx Biosciences' Leases rose 29370.49% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 29370.49%. This contributed to the annual value of $7.3 million for FY2024, which is 14857.72% up from last year.
- As of Q3 2025, Inhibrx Biosciences' Leases stood at $6.0 million, which was up 29370.49% from $6.5 million recorded in Q2 2025.
- Inhibrx Biosciences' 5-year Leases high stood at $7.3 million for Q4 2024, and its period low was $1.5 million during Q3 2024.
- Its 3-year average for Leases is $4.7 million, with a median of $6.0 million in 2025.
- Its Leases has fluctuated over the past 5 years, first skyrocketed by 14857.72% in 2024, then skyrocketed by 29370.49% in 2025.
- Quarter analysis of 3 years shows Inhibrx Biosciences' Leases stood at $3.0 million in 2023, then skyrocketed by 148.58% to $7.3 million in 2024, then dropped by 18.18% to $6.0 million in 2025.
- Its Leases was $6.0 million in Q3 2025, compared to $6.5 million in Q2 2025 and $6.9 million in Q1 2025.